NIH-funded research R21 grant

Increasing access to nicotine replacement therapy in community stores

Official title: Evaluating a novel policy to increase access to nicotine replacement therapy in community retailers

Funded at Rutgers Biomedical and Health Sciences · NIH-10790803 · Data updated 2026-11-12

This study is looking at a new rule that makes it easier for people in certain neighborhoods to buy products that help them quit smoking, and it wants to see how well stores are following this rule and how it helps people get the support they need to stop smoking, especially in communities that have been affected by tobacco use.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$395,051
NIH project number1R21CA287170-01
Project IDNIH-10790803 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living in communities with high tobacco product exposure and limited access to pharmacies, particularly from diverse racial and ethnic backgrounds.

Less likely to help

Patients who do not smoke or are not interested in quitting smoking may not benefit from this research.

What this research studies

This research investigates a new policy that requires community retailers to sell nicotine replacement therapy (NRT) products, aiming to improve access for individuals in areas with high tobacco exposure and limited pharmacy access. The project will assess how well these retailers comply with the new law and analyze its impact on NRT sales and calls to quit smoking services. By focusing on diverse neighborhoods, the research seeks to understand the effects of this policy on different racial and ethnic groups, ultimately aiming to reduce health disparities related to tobacco use.

Why it matters

Potential benefit: If successful, this research could significantly improve access to smoking cessation resources for underserved populations, helping more individuals quit smoking.

How similar studies have gone: Similar policy interventions in other regions have shown promise in increasing access to cessation resources, suggesting potential success for this approach.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Hrywna, Maria — Rutgers Biomedical and Health Sciences
  • Study coordinator: Hrywna, Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.